COTEAUBeta Get App
CBZ

CBZ

CBIZ, Inc.
$54.78
+0.00% Oct 19 close
Industrials
-52%-34%-17%0%+17%Oct 2025Oct 2026Apr 2026
CBZSPY
1W
+0.0%
1M
+0.3%
3M
+31.0%
6M
+79.2%
YTD
+8.6%
1Y
+6.8%

Live chart

Loading live chart…

What they do

CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, national technology, and government healthcare consulting services.

Industrials · Specialty Business Services

For information only · Important disclosures

Grades vs sector

No sector grades for CBZ yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
CBIZ Earnings Up In Q3
Nasdaq · Oct 19

Key stats

Market value$3.0B
P/E (last 12 months)23.0
P/E (next 12 months, estimated)12.3
52-week range$24.29 – $56.41
Revenue growth (latest quarter vs a year ago)-0.2%
Dividend yieldNo dividend
Analyst consensusHold (2)
Average analyst price target$55.00 (+0%)
Valuation and fundamentals

Valuation & fundamentals

Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +2 (DCF counts double).
▲DCF (base case)above the price by 110%
▲Piotroski F-score7/9
•Altman Z1.9 (grey)
▼Net debt / EBITDA5.0x

Discounted cash flow

Bear
$61
+12%
growth 7% · disc. 9.8% · term. 2.0%
Base
$115
+110%
growth 12% · disc. 8.8% · term. 2.5%
Bull
$193
+251%
growth 16% · disc. 7.8% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal
Today's price assumes free cash flow grows about 3% a year for 10 years.
Implied
+3%/yr
FCF, last 3 yrs
+14%/yr
FCF, last 5 yrs
+5%/yr
Revenue, last 3 yrs
+25%/yr
Revenue, last 5 yrs
+23%/yr
Same inputs as the DCF above: trailing free cash flow 0.3B, 8.8% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 0.92 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Forward EPS $4.46 vs trailing $2.38 (+88% expected growth). Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin
12.2%
Operating margin
6.9%
FCF margin
9.9%
Net margin
4.4%
Return on equity
6.5%
Return on invested capital
4.2%
Net debt / EBITDA
5.0×
Current ratio
1.5×
Interest cover
1.9×
Cash conversion (OCF/NI)
2.4×
Piotroski F-score 7/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✓ Gross margin improved✓ Asset turnover improved

Altman Z-score 1.9 (grey zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target
$55
+0%
Analysts
2
Hold
Range
$55–$55
low – high

Annual history

FYRevenueNet incomeFree cash flow
2025$2.8B$115.4M$175.5M
2024$1.8B$41.0M$110.8M
2023$1.6B$121.0M$130.5M
2022$1.4B$105.4M$117.5M
2021$1.1B$70.9M$122.2M
2020$963.9M$78.3M$135.3M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +25.0%.

Earnings

Next report: 2027-02-24 · before open · EPS est -0.51
25-0225-0425-0725-1026-0226-0426-0726-10-0.702.50
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-10-191.261.21-4.0%
2026-07-290.720.91+26.1%
2026-04-292.272.50+10.1%
2026-02-25-0.66-0.70-6.2%
2025-10-290.901.01+12.6%
2025-07-300.840.95+12.7%
2025-04-242.112.29+8.7%
2025-02-26-0.29-0.20+31.0%

Quarterly revenue

QuarterRevenueYoY
2026-06-30$682.2M-0.2%
2026-03-31$848.6M–
2025-12-31$542.7M–
2025-09-30$693.8M–
2025-06-30$683.5M–
Analyst actions
William Blair
2026-09-23 · down
Outperform → Market Perform
Barrington Research
2026-09-16 · down
Outperform → Market Perform
CJS Securities
2026-07-30 · down
Market Outperform → Market Perform
PT $55
Barrington Research
2026-06-24 · init
→ Outperform
PT $45
Stephens & Co.
2026-04-10 · init
→ Equal-Weight
PT $31
BMO Capital
2026-03-30 · init
→ Outperform
PT $33

Stats refreshed 2026-10-21 15:07:58 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

COTEAU

Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app

Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.

Beta 0.9 · Oct 21, 2026